Ivosidenib: First Global Approval.

Discussion Board › Forums › New Developments › Ivosidenib: First Global Approval.

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • September 15, 2018 at 10:39 am #97504
    gavin
    Moderator

    Hi Mary,

    Glad to be of help as always! Thanks to you for the extra info as well re the AG-120 and some of our members taking part in that trial. I did a search for AG-120 on the boards so that that info is in this post and this is what came up –

    https://cholangiocarcinoma.org/db/search/AG-120/

    Thanks as always Mary!

    Gavin

    September 14, 2018 at 9:43 am #97497
    bglass
    Moderator

    Thank you, Gavin, for posting this.

    Ivosidenib is the newer name for the drug formerly known as AG-120.  Some of our folks participated in trials for this drug, which targets the IDH1 mutation.  If you use the discussion board search engine for “AG-120” you can read their posts.

    September 14, 2018 at 8:49 am #97496
    gavin
    Moderator

    Ivosidenib: First Global Approval.

    https://www.ncbi.nlm.nih.gov/pubmed/30209701

  • Author
    Posts
Viewing 3 posts - 1 through 3 (of 3 total)
  • The forum ‘New Developments’ is closed to new topics and replies.